Led · Series A · Jan 2026

Salvo Health offers brick-and-mortar gastrointestinal (GI) clinics a continuous virtual care platform that connects patients with a specialized, gut-focused care team. Users gain direct, ongoing access to registered dietitians, behavioral-health professionals, and nurses, helping clinics save time, boost revenue, and improve outcomes. In 2025 the company reported 800% year-over-year growth in both patients and revenue and expanded enterprise agreements with GI doctors by more than 1,000%, reaching 801 signed GI partners. Led by CEO Jeffrey Glueck, COO Marin Rothenberg, and CMO Dr. Erin Hendriks, the company is now building an AI-driven product roadmap. The new funding will finance engineering expansion and nationwide hiring of additional clinical staff to meet rising demand. Salvo Health positions itself at the intersection of virtual specialty care and chronic condition management, with ambitions to scale its platform nationally.

Participated · Series A · Dec 2025

Clarity Pediatrics operates a tech-enabled virtual clinic that delivers American Academy of Pediatrics–aligned specialty care for chronic pediatric conditions such as ADHD and anxiety. More than 1,600 pediatricians in California and Texas already refer both commercial and Medicaid patients to the service, which integrates medical oversight, behavioral therapy, and parent coaching, all covered by insurance. Outcomes to date are encouraging: 89% of participating parents report a ‘large’ impact on their lives and 75% see improvement in child behaviors after eight weeks. The company plans to launch obesity care in early 2026, broadening its multi-specialty offering to address one of the fastest-growing pediatric health issues. Funding will also support continued development of its virtual platform and geographic expansion across the United States. Clarity’s model emphasizes family-centered group care delivered by pediatricians and specialists working at the top of their licenses. The company is headquartered in San Francisco and is backed by several prominent venture investors.

Participated · Seed · Dec 2025

Auxira Health operates a virtual cardiology platform that pairs advanced practice providers, medical assistants and registered nurses with cardiology practices as fully integrated remote “pods.” These virtual teams handle clinical and administrative tasks, allowing on-site cardiologists to see more patients and reduce workload. The company partners with cardiology groups and health systems nationwide, positioning its service as a scalable way to address specialist shortages and administrative burden. Led by CEO Inna Plumb, Auxira Health is building out technology and operational infrastructure to support seamless integration with partner clinics. The firm plans to hire additional clinicians and support staff to meet rising demand. By mid-2026, management expects the platform to support more than 100 cardiologists. The recent seed funding provides the financial runway to accelerate these growth initiatives and deepen product capabilities.

Participated · Seed · Dec 2025

BoodleBox offers a single, secure interface that aggregates leading AI models such as GPT-5.1, Claude, Gemini, Perplexity, and LLAMA, enabling responsible, multi-user collaboration. Its proprietary token-reduction technology can lower AI operating costs and environmental impact by up to 96 % while maintaining enterprise-grade security and FERPA compliance. Launched in Q4 2024, the platform is already used at more than 1,200 higher-education institutions and over 100 workforce teams, with 80 institutions deploying BoodleBox’s AI infrastructure to serve 70,000+ faculty, staff, and students. Key features include custom bot building, AI coaching, team collaboration, and data portability that lets graduates retain their AI-assisted work. The company addresses the widening AI-skills gap by providing affordable access to tools that 66 % of employers now require, yet only 24 % of low-income students can reach. With fresh capital, BoodleBox plans to deepen its higher-ed presence, enhance product capabilities, and enter sectors such as corporate training, public sector, and specialized industries. It will also relocate its headquarters to Colorado Springs, Colorado, to capitalize on a favorable business environment and tech talent pool.

Participated · Equity · Oct 2025

Andel is building a cooperative pharmacy-benefit platform that pools the buying power of employer members to buy GLP-1 weight-loss medications and other costly branded drugs directly from manufacturers at below-market rates. Employers choose a subsidy level, and Andel handles prescription verification, payment, and next-day delivery through its native applications and wholly owned Andel Pharmacy, LLC. By bypassing traditional pharmacy-benefit managers, the model aims to lower costs for employers while giving employees immediate access to brand-name medicines without prior-authorization hurdles. Co-founders Jay Bregman—whose prior ventures include Hailo and Thimble—and pharmacist Ritu Malhotra, PharmD, combine startup and healthcare-benefits expertise to navigate the complex drug-pricing ecosystem. The company announced plans to launch nationwide in early 2026. Andel has raised $4.5 million to fund this rollout, but it has not yet disclosed revenue, user, or prescription-volume metrics.